Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 571 AL 585

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention

Tansey MG, Goldberg MS.

Neurobiol Dis. 2010 Mar;37(3):510-8. doi: 10.1016/j.nbd.2009.11.004. Epub 2009 Nov 10.

Dopamine receptor D4 polymorphism predicts the effect of L-DOPA on gambling behavior

Eisenegger C, Knoch D, Ebstein RP, Gianotti LR, Sándor PS, Fehr E.

Biol Psychiatry. 2010 Apr 15;67(8):702-6. doi: 10.1016/j.biopsych.2009.09.021. Epub 2009 Nov 14.

Comparison among probabilistic neural network, support vector machine and logistic regression for evaluating the effect of subthalamic stimulation in Parkinson disease on ground reaction force during gait

Muniz AM, Liu H, Lyons KE, Pahwa R, Liu W, Nobre FF, Nadal J.

J Biomech. 2010 Mar 3;43(4):720-6. doi: 10.1016/j.jbiomech.2009.10.018. Epub 2009 Nov 14.

Transient gender-related effects in Parkinson's disease patients with subthalamic stimulation

Romito LM, Contarino FM, Albanese A.

J Neurol. 2010 Apr;257(4):603-8. doi: 10.1007/s00415-009-5381-2. Epub 2009 Nov 18.

New Vistas on Parkinson's disease

Willis GL, Armstrong SM.

Eur J Neurol. 2010 Apr;17(4):519-20. doi: 10.1111/j.1468-1331.2009.02852.x. Epub 2009 Nov 18.

The FRAGAMP study: environmental and genetic factors in Parkinson's disease, methods and clinical features

Nicoletti A, Pugliese P, Nicoletti G, Arabia G, Annesi G, De Mari M, Lamberti P, Gallerini S, Marconi R, Epifanio A, Morgante L, Cozzolino A, Barone P, Torchia G, Quattrone A, Zappia M.

Neurol Sci. 2010 Feb;31(1):47-52. doi: 10.1007/s10072-009-0182-z.

Parkinson's disease: Exit toxins, enter genetics

Westerlund M, Hoffer B, Olson L.

Prog Neurobiol. 2010 Feb 9;90(2):146-56. doi: 10.1016/j.pneurobio.2009.11.001. Epub 2009 Nov 17.

Some current insights into oxidative stress

Ďuračková Z.

Physiol Res. 2010;59(4):459-469. doi: 10.33549/physiolres.931844. Epub 2009 Nov 20.

Clinical experiences with levodopa methylester (melevodopa) in patients with Parkinson disease experiencing motor fluctuations: an open-label observational study

Zangaglia R, Stocchi F, Sciarretta M, Antonini A, Mancini F, Guidi M, Martignoni E, Pacchetti C.

Clin Neuropharmacol. 2010 Mar-Apr;33(2):61-6. doi: 10.1097/WNF.0b013e3181c5e60c.

A multicenter, long-term study on arrhythmias in children with Ebstein anomaly

Delhaas T, Sarvaas GJ, Rijlaarsdam ME, Strengers JL, Eveleigh RM, Poulino SE, de Korte CL, Kapusta L.

Pediatr Cardiol. 2010 Feb;31(2):229-33. doi: 10.1007/s00246-009-9590-3.

CAS proteins in normal and pathological cell growth control

Tikhmyanova N, Little JL, Golemis EA.

Cell Mol Life Sci. 2010 Apr;67(7):1025-48. doi: 10.1007/s00018-009-0213-1. Epub 2009 Nov 25.

Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease

Lee SH, Kim MJ, Kim BJ, Kim SR, Chun S, Ryu JS, Kim GS, Lee MC, Koh JM, Chung SJ.

Mov Disord. 2010 Feb 15;25(3):332-40. doi: 10.1002/mds.22866.

Pain and dyskinesia in Parkinson's disease

Juri C, Rodríguez-Oroz MC, Burguera JA, Guridi J, Obeso JA.

Mov Disord. 2010 Jan 15;25(1):130-2. doi: 10.1002/mds.22874.

Psychometric properties of the SCOPA-AUT Brazilian Portuguese version

Carod-Artal FJ, Ribeiro Lda S, Kummer W, Martinez-Martin P.

Mov Disord. 2010 Jan 30;25(2):205-12. doi: 10.1002/mds.22882.

A positive influence of vision on motor symptoms during sensory attention focused exercise for Parkinson's disease

Sage MD, Almeida QJ.

Mov Disord. 2010 Jan 15;25(1):64-9. doi: 10.1002/mds.22886.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias